Wantai Bio redeems 700m yuan cash management product
Beijing Wantai Biological Pharmacy Enterprise redeemed a 700 million yuan structured deposit product that matured on July 30, 2025.
The company invested the funds in an ICBC structured deposit for institutional clients in July 2024. The investment generated a profit of 18.2 million yuan, which was transferred to the company's fundraising account on July 31.
The company had previously secured board approval to invest up to 1.5 billion yuan of idle raised funds in secure, liquid products with maximum 12-month terms.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Beijing Wantai Biological Pharmacy Enterprise publishes news
Free account required • Unsubscribe anytime